Clinical benefit of transcutaneous afferent patterned stimulation (TAPS) in essential tremor patients with high unmet need: a secondary analysis of TAPS studies.

Stuart H Isaacson¹, Rajesh Pahwa², Salima Brillman³, Chiahao Lu⁴, Alexander R Kent⁴

¹Parkinson's Disease and Movement Disorders of Boca Raton, Boca Raton, FL, USA.

²Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

³Parkinson's Disease and Movement Disorders Center of Silicon Valley, Palo Alto, CA, USA.

⁴Cala Health Inc, San Mateo, CA, USA.

PubMed DOI

Abstract

BACKGROUND: Transcutaneous afferent patterned stimulation (TAPS) is a noninvasive neuromodulation therapy that improves hand tremor in essential tremor (ET) patients. The benefits of TAPS in ET patients with high unmet need (severe tremor, non-responsive to medication, age ≥65 years) and early responders (substantial TAPS tremor improvement in the first month) remains unknown. RESEARCH DESIGN AND…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.